CS060304

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameCS060304
Drug Alias NameCS060304CS-060304
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor beta-1 agonists
TargetsThyroid hormone receptor beta
Therapy Area/IndicationsHomozygous familial hypercholesterolemiaMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCascade Pharmaceuticals Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCascade Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHomozygous familial hypercholesterolemiaMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A